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Abstract
Brucellosis is one of the most common and economically important zoonotic 
diseases globally. Office International des Epizooties (OIE) listed it as the second 
most important zoonotic disease. The disease affects almost all animals but impor-
tantly buffalo. The disease manifests itself in the form of abortion, still births, 
weak calves, infertility, and specific lesions on reproductive organs. It is prevalent 
worldwide but still a neglected disease. As a zoonotic disease its importance is 
multifarious for animals as well as public health. Taking into account poor health 
facilities and unawareness, its control becomes very significant. The difficulty to 
treat this disease and its zoonotic potential compel slaughtering as a best strategy 
to get rid of this disease. There are not too many therapeutic trials conducted to 
control bovine brucellosis. Instead many therapeutic trials have been conducted for 
treating human brucellosis. The therapeutic trial requires long term administration 
of drugs (almost 6 weeks) without any surety of complete recovery so it is a pre-
ferred practice to eradicate the animal or sell it out instead of treating.
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1. Introduction
Brucellosis is one of the most common and economically important zoonotic 
diseases globally [1]. It was first discovered by Bruce in 1887. It is also known as 
undulant fever, Mediterranean fever, Epizootic abortion, Enzootic abortion, Malta 
fever, and Bang’s disease [2, 3]. It is considered as the most rapidly spreading disease 
by the World Health Organization (WHO), Food and Agriculture Organization 
(FAO), and Office International des Epizooties (OIE) [4]. Significant economic 
losses due to brucellosis are abortion, low milk yield, low conception rate and cull-
ing of animal [5]. Central Asia, the Middle East and adjacent subtropical geogra-
phies are among those with the highest incidence of brucellosis among humans 
and livestock worldwide [6]. There is a reason to believe that the burden caused 
by brucellosis in low-income countries in Asia and Africa is large [1]. Important 
animal species that can get this disease include cattle, buffalo, swine, sheep, goats, 
camels, dogs and being zoonotic can also infect humans [7]. Prevalence of brucel-
losis in Buffalo is 5.05% in Pakistan [8]. This is suggested by quite an old study and 
conduction of a new research is required to study the current trends of brucellosis 
in Pakistan. It is for sure that its prevalence has increased to threatening level.
Brucella is Gram-negative, nonmotile, coccobacilli or small rods intracellular 
pathogen that are taxonomically categorized in the in the class α-proteobacteria, order 
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Rhizobiales, family Brucellaceae. It is caused by ingestion of unpasteurized milk or 
undercooked meat from infected animals, or close contact with their secretions [3]. 
It is caused by different bacteria of the genus Brucella characterized by abortion epi-
didymis and orchitus. Brucellosis causes abortions in the third trimester of pregnancy 
when unvaccinated cattle are exposed to the infectious organism. Brucellosis has been 
reported since long in Pakistan and due to its increasing prevalence emphasis has been 
put on regular screening of livestock herds and of animals brought at abattoirs and at 
livestock markets [9]. The overall prevalence of brucellosis in Punjab is found to be 2.5%.
2. Diagnosis of brucellosis
Brucella spp. is considered as the most common laboratory-acquired pathogens. 
Several serological tests have been widely used for diagnosis of Brucella such are 
Rose Bengal plate test (RBPT), standard tube agglutination test (STAT), comple-
ment fixation test (CFT), enzyme linked immunosorbant assay (ELISA). Besides 
these, polymerase chain reaction (PCR)-based identification and typing and fluo-
rescence polarization assays (FPA) are also important diagnostic tools [10]. These 
all diagnostic tools have been employed by various researchers to find out brucel-
losis. Shafee and other in 2011 used MRT and i-ELISA to find out overall prevalence 
of brucellosis in Quetta, capital of Baluchistan province of Pakistan [11].
ELISA and PCR are more specific tests to diagnose brucellosis but there are 
various limitations to these tests. Both of these tests are expansive and need sophis-
ticated equipment to perform. Both cannot be performed in field conditions.
2.1 Therapeutic trial of brucellosis
The bovine brucellosis is very prevalent but a neglected disease on the whole. The 
countries which are declared as Brucella free countries managed to attain this status 
through slaughtering and destroying the Brucella positive animals along with effective 
vaccination. The literature confirmed that no country overcome it through treating 
the Brucella positive animals. The main reason behind this practice is the long dura-
tion of therapeutic trial, i.e., almost 6 weeks without any surety of complete recovery. 
In most of the cases, animals relapse the disease or act as a carrier for rest of their life.
Alavi and Ali Reza treated Brucella positive patients with doxycycline-rifampin 
and doxycycline-cortimoxazol and compared their efficacy. They concluded that 
the later combination has a better efficacy than former [12]. In another study the 
therapeutic efficacy of doxycycline and rifampicin (DR) with a doxycycline plus 
streptomycin (DS) were compared. It was concluded that doxycycline-aminoglyco-
side combination has a better efficacy and doxycycline-rifampin and doxycycline-
cotrimoxazole should be the alternative regimens [10].
Hari and Sughanda conducted a different type of research and checked immuno-
therapeutic response in cattle using a specific biomarker. They are against brucellosis. The 
SL induced strong antibody response and RL reported successful use of phage lysates of 
RB51 (RL) and S19 (SL) against brucellosis. The SL induced strong antibody response and 
RL stimulated cell mediated immunity (CMI). Other than these, no therapeutic trial are 
available in literature for evaluation. The reasons of which have already been discussed.
3. Conclusions
Although bovine brucellosis is very prevalent and now reemerging still no 
therapeutic trial has been conducted since now. The main reasons behind include 
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the complex nature of Brucella infection, long duration of therapy, and relapse of 
disease after treatment.
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